April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Genetic and epigenetic evidence for a pathway involving lipid metabolism and HTRA1 in AMD pathophysiology.
Margaret M DeAngelis; Margaux A Morrison; Jeeyun Ahn; Evangeline E Tsironi; Silvestri Giuliana; M Elizabeth Hartnett; Joan W Miller; Kyu Hyung Park; Ivana K Kim; Lindsay Farrer
Author Affiliations & Notes
  • Margaret M DeAngelis
    Dept of Ophthalmology, University of Utah, Salt Lake City, UT
  • Margaux A Morrison
    Dept of Ophthalmology, University of Utah, Salt Lake City, UT
  • Jeeyun Ahn
    Dept. of Ophthalmology, Seoul National University Bundang Hospital, Kyeounggi, Republic of Korea
  • Evangeline E Tsironi
    Dept. of Ophthalmology, University of Thessaly School of Medicine, Larissa, Greece
  • Silvestri Giuliana
    Centre for Vision and Vascular Science, Queen, Belfast, United Kingdom
  • M Elizabeth Hartnett
    Dept of Ophthalmology, University of Utah, Salt Lake City, UT
  • Joan W Miller
    Retina Service, Harvard Medical School, Mass Eye and Ear Infirmary, Boston, MA
  • Kyu Hyung Park
    Dept. of Ophthalmology, Seoul National University Bundang Hospital, Kyeounggi, Republic of Korea
  • Ivana K Kim
    Retina Service, Harvard Medical School, Mass Eye and Ear Infirmary, Boston, MA
  • Lindsay Farrer
    Departments of Medicine (Section of Biomedical Genetics), Ophthalmology and Biostatistics, Neurology, Epidemiology, Boston University, Boston, MA
  • Footnotes
    Commercial Relationships Margaret DeAngelis, Massachusetts Eye and Ear Infirmary (P); Margaux Morrison, Massachusetts Eye and Ear Infirmary (P); Jeeyun Ahn, None; Evangeline Tsironi, None; Silvestri Giuliana, Allergan (C), Bayer (C); M Elizabeth Hartnett, None; Joan Miller, Alcon (C), Imagen Biotech, Inc. (C), ISIS Pharmaceuticals, Inc. (C), KalVista Pharmaceuticals (C), Maculogix, Inc (C), Massachusetts Eye and Ear Infirmary (P), ONL Therapeutics, LLC (C), Regeneron Pharmaceuticals, Inc. (C); Kyu Hyung Park, None; Ivana Kim, None; Lindsay Farrer, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 2185. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Genetic and epigenetic evidence for a pathway involving lipid metabolism and HTRA1 in AMD pathophysiology.
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      Margaret M DeAngelis, Margaux A Morrison, Jeeyun Ahn, Evangeline E Tsironi, Silvestri Giuliana, M Elizabeth Hartnett, Joan W Miller, Kyu Hyung Park, Ivana K Kim, Lindsay Farrer; Genetic and epigenetic evidence for a pathway involving lipid metabolism and HTRA1 in AMD pathophysiology.. Invest. Ophthalmol. Vis. Sci. 2014;55(13):2185.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: To investigate the previously reported hypothetical network of age related macular degeneration (AMD)-associated genes based on pathway analysis of Affy 6.0 microarray gene expression data from lymphoblastoid cell lines (LCLs) of those with and without AMD.

Methods: We genotyped TagSNPs from genes within the pathway (RGS13, CXCL13, RPS6KA2, ABCA1, and NLRP2), and performed gene-gene interaction analysis of the TagSNPs and previously reported AMD-associated SNPs from genes within the pathway (ARMS2, HTRA1, ROBO1, and RORA) in 4 cohorts (n = 2,224) representing all subtypes of AMD of varying ethnicities. We performed ChIP-Seq on DNA from LCLs of patients with and without AMD. To interrogate methylation status, bisulfite sequencing was performed on DNA and tissue from the retina and RPE/choroid of fresh donor eyes with and without AMD. This fresh eye tissue was also used to perform differential gene expression analysis using RT-PCR.

Results: Employing a cases-only approach and meta-analysis, we found significant gene-gene interaction between the previously reported AMD genes ARMS2, HTRA1, ROBO1, and RORA and TagSNPs within ABCA1, RGS13, and RPS6KA2 (p<.01). ChIP-Seq analysis did not reveal any significant binding results. Three methylated CpG sites within ABCA1 were significantly associated with decreased risk of all AMD subtypes (p<.05). Gene expression analysis using fresh donor eye tissue revealed significantly decreased RGS13 and RORA expression within the macular retina tissue of AMD eyes compared to normal (p=.009 and .001, respectively). In the macula RPE of AMD eyes, significantly decreased expression was observed for both ABCA1 and ROBO1 compared to those without AMD (p=.016 and .039, respectively). All other genes examined, while expressed in both the macula and extra macula retina and RPE/choroid, did not show differential expression between AMD and normal eyes (n = 18). Further IPA pathway analysis of the significant genes showed this pathway to be involved in lipid metabolism.

Conclusions: We describe several lines of evidence, including gene-gene interaction, gene expression data, and tissue specific methylation that support the role of this previously reported hypothetical network in AMD pathogenesis. Further pathway analysis with these genes, including HTRA1, showed they may be involved in lipid metabolism and underlie AMD pathophysiology.

Keywords: 412 age-related macular degeneration  
© 2014, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2024 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept